NNC 01-0687, a selective dopamine D1 receptor antagonist, in the treatment of schizophrenia

Psychopharmacology (Berl). 1995 Oct;121(3):328-9. doi: 10.1007/BF02246071.
No abstract available

Publication types

  • Clinical Trial
  • Letter

MeSH terms

  • Adult
  • Benzazepines / adverse effects*
  • Benzazepines / therapeutic use*
  • Benzofurans / adverse effects*
  • Benzofurans / therapeutic use*
  • Dopamine Antagonists / therapeutic use*
  • Follow-Up Studies
  • Humans
  • Male
  • Placebo Effect
  • Receptors, Dopamine D1 / antagonists & inhibitors*
  • Schizophrenia / drug therapy*
  • Treatment Outcome

Substances

  • Benzazepines
  • Benzofurans
  • Dopamine Antagonists
  • Receptors, Dopamine D1
  • 5-(2,3-dihydrobenzofuran-7-yl)-3-methyl-8-nitro-2,3,4,5-tetrahydro-1H-3-benzazepin-7-ol